pharma · HR-positive, HER2-negative Advanced Breast Cancer · Hyperglycemia
Chia Tai Tianqing
Chia Tai Tianqing Pharmaceutical Group Co.,
Chia Tai Tianqing is a pharma organization headquartered in CN. Primary therapeutic focus areas include HR-positive, HER2-negative Advanced Breast Cancer, Hyperglycemia. NovaPharmaNews links 2 clinical program(s), 0 drug
Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Lianyungang, CN
- Employees
- 366
- Programs
- 2
- Drugs
- 3
- Patents
- 0
TQF3250 placebo
Phase 1 · small molecule · Hyperglycemia
TQF3250 placebo for Hyperglycemia is a Phase 1 program (small_molecule) at Chia Tai Tianqing Pharmaceutical Group Co., with 1 ClinicalTrials.gov record(s).
Internal code TQF3250-Ia-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co.,
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Hyperglycemia
- Status
- active
- Trials
- 1